Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Nuwellis (NUWE) Research & Development (2016 - 2025)

Nuwellis filings provide 14 years of Research & Development readings, the most recent being $884000.0 for Q4 2025.

  • On a quarterly basis, Research & Development rose 6.38% to $884000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.7 million, a 15.49% decrease, with the full-year FY2025 number at $2.7 million, down 15.49% from a year prior.
  • Research & Development hit $884000.0 in Q4 2025 for Nuwellis, up from $603000.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $1.7 million in Q3 2021 to a low of $486000.0 in Q3 2024.
  • Median Research & Development over the past 5 years was $1.1 million (2022), compared with a mean of $1.0 million.
  • Biggest five-year swings in Research & Development: skyrocketed 98.16% in 2021 and later crashed 62.92% in 2024.
  • Nuwellis' Research & Development stood at $1.1 million in 2021, then grew by 6.19% to $1.2 million in 2022, then grew by 14.24% to $1.4 million in 2023, then plummeted by 39.43% to $831000.0 in 2024, then grew by 6.38% to $884000.0 in 2025.
  • The last three reported values for Research & Development were $884000.0 (Q4 2025), $603000.0 (Q3 2025), and $675000.0 (Q2 2025) per Business Quant data.